Company intelligence / Profile preview
ImQuest BioSciences
- Ownership
- Private
- Development stage
- Other
Overview
ImQuest BioSciences is a preclinical CRO with over 30 years of expertise in evaluating small molecules, biologics, vaccines, antimicrobial peptides, and antibodies for infectious disease, cancer, and inflammatory disease. The company has supported multiple drug candidates through discovery to preclinical/IND stages. Notable internal pipeline assets include IQP‑0410 for HIV infection at the IND application stage. The company’s immunomodulatory platform focuses on restoring Th1/Th2 immune balance. Some programs have been discontinued or are pending further development.
- Therapeutic areas
- OncologyImmunologyInfectious Diseases
- Modalities
- Small moleculeBiologicVaccineAntimicrobial peptideTherapeutic antibody
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on ImQuest BioSciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ImQuest BioSciences.